Orion News
Most Popular Orion Story
FDA reviewing possible Stalevo-prostate cancer link
The FDA says it is evaluating clinical trial data that suggests that patients taking Stalevo, Novartis and Orion's Parkinson's disease treatment, may be at an increased risk for developing prostate Read more...
Latest Headlines
- April 1, 2010
- September 14, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
